Robert E. Morales

Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity

Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR

Dendritic cells in cancer immunology and immunotherapy

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Delivery technologies for cancer immunotherapy

Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

New treatment strategies for HPV-positive head and neck cancer

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

AI-2 quorum-sensing inhibitors affect the starvation response and reduce virulence in several Vibrio species, most likely by interfering with LuxPQ

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

Effect of Essential Oils on Pathogenic Bacteria

Recent Progress in GM-CSF-Based Cancer Immunotherapy

Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)

inducTION of mage‐A3 and HPV‐16 immunity by Trojan vaccines in patients with head and neck carcinoma

Successful Outcome of Progressive Multifocal Leukoencephalopathy in a Renal Transplant Patient

Vibrio vulnificus infection: diagnosis and treatment.